Buyon, JP, Clancy, RM. Neonatal lupus: review of proposed pathogenesis and clinical data from the US-based Research Registry for Neonatal Lupus. Autoimmunity
2003; 36: 41–50.
Saxena, A, Izmirly, PM, Han, SW, et al. Serum biomarkers of inflammation, fibrosis and cardiac function in facilitating diagnosis, prognosis and treatment of Anti-SSA/Ro-associated cardiac neonatal lupus. J Am Coll Cardiol
2015; 66: 930–939.
Costedoat-Chalumeau, N, Amoura, Z, Villain, E, et al. Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther
2005; 7: 69–73.
Nield, LE, Silverman, ED, Smallhorn, JF, et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular block. J Am Coll Cardiol
2002; 40: 796–802.
Vinet, E, Pineau, CA, Scott, S, et al. Increased congenital heart defects in children born to women with systemic lupus erythematosus: results from the offspring of Systemic Lupus Erythematosus Mothers Registry Study. Circulation
2015; 131: 149–156.
Zuily, S, Regnault, V, Selton-Suty, C, et al. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies. Circulation
2011; 124: 215–224.
Veerbhadran, SP, Pillai, VV, Sasidharan, B, et al. Surgery for congenital tricuspid valve cleft: tricuspid valve repair with neochordae and annuloplasty. J Heart Valve Dis
2015; 24: 525–527.
Boon, R, Hazekamp, M, Hoohenkerk, G, et al. Artificial chordae for pediatric mitral and tricuspid valve repair. Eur J Cardiothorac Surg
2007; 32: 143–148.